Japan Construction Market Segmentation
Construction By Therapeutic Area (USD Million, 2025-2035)
- Oncology
- Autoimmune Diseases
- Infectious Diseases
Construction By Cell Source (USD Million, 2025-2035)
- Autologous
- Allogeneic
- Gene-Edited
Construction By Indication (USD Million, 2025-2035)
- Acute Lymphoblastic Leukemia
- Non-Hodgkin Lymphoma
- Multiple Myeloma
Construction By End User (USD Million, 2025-2035)
- Hospitals
- Research Institutes
- Cancer Treatment Centers